Comparison of cardiovascular disease risk assessment tools in primary prevention patients with raised lipoprotein(a)

被引：0
|
作者：
Carlton, H. C. [1 ]
Banerjee, A. [2 ]
Burnett, D. [3 ]
Shipman, K. E. [4 ]
机构：
[1] Univ Hosp Sussex NHS Trust, Dept Clin Chem, Chichester, England
[2] Univ Hosp Sussex NHS Trust, Dept Cardiol, Chichester, England
[3] Worthing Dist Hosp, Dept Cardiol, Worthing, England
[4] Brighton & Sussex Med Sch, Dept Med Educ, Brighton, England
来源：
EUROPEAN HEART JOURNAL | 2024年 / 45卷
关键词：
D O I：
10.1093/eurheartj/ehae666.2709
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] LIPOPROTEIN(A) AND VASCULAR RISK IN PATIENTS WITH ESTABLISHED CARDIOVASCULAR DISEASE
    Saely, Christoph H.
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Mutschlechner, Beatrix
    Zanolin-Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 1515 - 1515
  • [32] Frequency of lipoprotein(a) measurements in patients with or at risk of cardiovascular disease
    Upadhyaya, Bhavana
    Wang, Ying
    Bruckel, Jeffrey
    Block, Robert C.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2023, 17 (06) : 743 - 747
  • [33] Lipoprotein(a) and Vascular Risk in Patients with Established Cardiovascular Disease
    Saely, Christoph H.
    Sprenger, Lukas
    Vonbank, Alexander
    Larcher, Barbara
    Mader, Arthur
    Maechler, Maximilian
    Purin, Daniela
    Leiherer, Andreas
    Muendlein, Axel
    Drexel, Heinz
    DIABETES, 2020, 69
  • [34] Do currently recommended risk prediction tools help primary prevention of cardiovascular disease in Chinese population?
    Wu, Hai-Yun
    Wu, Liu-Xin
    Zen, Qiang
    Qiang, Dong-Chang
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 146 (02) : 299 - 301
  • [35] Statins for the primary prevention of cardiovascular disease in low cardiovascular risk Koreans
    Kim, JuYoung
    Ryou, Insun
    Park, Hwa Yeon
    Oh, Sohee
    Kim, JeongHyun
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 399 - 399
  • [36] OVERWEIGHT OR OBESITY FOR PRIMARY PREVENTION OF CARDIOVASCULAR DISEASE IN THE PRIMARY CARE SETTING AND CARDIOVASCULAR RISK
    Rodriguez, J.
    Villaverde, C.
    Perez, J.
    Panisello, J.
    Bleda, D.
    Trave, P.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [37] Cardiovascular disease risk assessment and prevention in blood donors
    Kessler, Debra A.
    Ortiz, Caroline
    Grima, Kathleen
    Vlahov, David
    Nandi, Vijay
    Jones, Robert
    Hillyer, Christopher D.
    Shaz, Beth H.
    TRANSFUSION, 2012, 52 (10) : 2174 - 2182
  • [38] Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting
    Verbeek, Rutger
    Hoogeveen, Renate M.
    Langsted, Anne
    Stiekema, Lotte C. A.
    Verweij, Simone L.
    Hovingh, G. Kees
    Wareham, Nicholas J.
    Khaw, Kay-Tee
    Boekholdt, S. Matthijs
    Nordestgaard, Borge G.
    Stroes, Erik S. G.
    EUROPEAN HEART JOURNAL, 2018, 39 (27) : 2589 - 2596
  • [39] Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
    Studzinski, Krzysztof
    Tomasik, Tomasz
    Krzyszton, Janusz
    Jozwiak, Jacek
    Windak, Adam
    BMJ OPEN, 2017, 7 (03):
  • [40] Raised Lipoprotein (a) Concentrations as an Independent Risk Factor for Cardiovascular Events
    Schatz, Ulrike
    Fischer, Sabine
    Julius, Ulrich
    Tselmin, Sergey
    Bornstein, Stefan
    DIABETES, 2010, 59 : A608 - A608
12345